title: [Essential thrombocythemia: therapy with alpha interferons].
authors.affiliation: Istituto di Ematologia L. e A. Seràgnoli, Università di Bologna.
authors.forename: L
authors.initials: L
authors.lastname: Gugliotta
authors.forename: L
authors.initials: L
authors.lastname: Catani
authors.forename: N
authors.initials: N
authors.lastname: Vianelli
authors.forename: M
authors.initials: M
authors.lastname: Mattioli Belmonte
authors.forename: M L
authors.initials: ML
authors.lastname: Cascione
authors.forename: M
authors.initials: M
authors.lastname: Bendani
authors.forename: R
authors.initials: R
authors.lastname: Fanin
authors.forename: M G
authors.initials: MG
authors.lastname: Michieli
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
authors.forename: S
authors.initials: S
authors.lastname: Tura
mesh_terms: D000917:Antibody Formation; D004341:Drug Evaluation; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007370:Interferon Type I / Q000276:immunology / Q000627:therapeutic use; D016898:Interferon-alpha / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D008533:Megakaryocytes / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects; D011994:Recombinant Proteins; D013920:Thrombocythemia, Essential / Q000628:therapy*
chemical_list: D007155:Immunologic Factors; D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Trombocitemia essenziale: la terapia con interferoni alpha.